CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

英国《自然》网站在日前的报道中指出，经过基因编辑的猪和绵羊等动物，正逐渐在农业领域获得认可。这些技术可提升动物的性状表现，为人类提供更安全、优质的肉类产品。但经CRISPR技术改造的马，却被马球比赛拒之门外。专家强调，必须严格追踪并确保基因编辑动物的安全性，审慎推进相关应用。 Kheiron公司以阿根廷一匹冠军马为原型，利用克隆技术培育出五匹遗传背景完全一致的克隆马。在此基础上，研究人员进一步应用 ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

Investigators have used base editing to create a treatment for multisystemic smooth muscle dysfunction syndrome, which has ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

By Michelle Yang Researchers from Mie University in Japan used the gene editing tool CRISPR to remove the extra chromosome 21, the copy responsible for Down syndrome. Courtesy of digitale.de via ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.